KRISTINE SILCOTT: Open Payments
NPI 1841813706 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 12 payments from 9 companies in 2025. Trend: 2023 $46 · 2024 $125 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| CeQur Corporation | 1 | $20 |
| LeMaitre Vascular, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: REXULTI, JOURNAVX, BREZTRI, CeQur Simplicity, ARTEGRAFT VASCULAR GRAFT, NURTEC ODT, Symbravo, LINZESS.
Industry payments across MO — which companies pay providers there.
